Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study

Journal of the National Cancer Institute

Volumn 92, Issue 23, 2000, Pages 1910-1917

  Stattin, Pär ^a   Bylund, Annika ^a   Rinaldi, Sabina ^b   Biessy, Carine ^b   Déchaud, Henri ^c   Stenman, Ulf Håkan ^d   Egevad, Lars ^e   Riboli, Elio ^b   Hallmans, Göran ^a   Kaaks, Rudolf ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Hopital de l'Antiquaille   (France)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SWEDEN;

EID: 0034614104     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.23.1910     Document Type: Article

References (48)

1. Insulin-like growth factors and their binding proteins: Biological actions
2. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
3. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells
4. Insulin-like growth factor I: Action and receptor characterization in human prostate cancer cell lines
5. Insulin-like growth factors and prostate cancer
6. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant
7. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
8. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
9. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
10. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
11. Nutritional regulation of the insulin-like growth factors
12. Prevention of prostate cancer and liver tumors in L-W rats by moderate dietary restriction
13. Insulin-like growth factor bioactivity and its modification in growth hormone resistant states
14. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
15. Free insulin-like growth factor I (IGF-I) in healthy subjects: Relationship with IGF-binding proteins and insulin sensitivity
16. Growth hormone in obesity
17. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression
18. Circulating IGF-I: New perspectives for a new century
19. Leptin is associated with increased risk of myocardial infarction
20. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978
21. Prostate cancer; primary registration in Northern Sweden
22. Histological typing of tumours. No. 22
23. Evaluation of the Abbott IMx Automated Immunoassay of Prostate-Specific Antigen
24. Body size and prostate cancer: A 20-year follow-up study among 135,006 Swedish construction workers
25. Total food consumption and body mass index in relation to prostate cancer risk: A case-control study in Sweden with prospectively collected exposure data
26. Smoking and risk of total and fatal prostate cancer in United States health professionals
27. Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial
28. Prostate cancer and smoking: A review of case-control and cohort studies
29. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study
30. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
31. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
32. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
33. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis; predominant impact of age, obesity, gonadal function, and sleep
34. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients (Oxf)
35. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
36. Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age
37. Height, body weight, and risk of prostate cancer
38. Anthropometry and prostate cancer risk: A prospective study of 22,248 Norwegian men
39. Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders
40. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period
41. Risk factors for prostate cancer: Results from the Canadian National Enhanced Cancer Surveillance System
42. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada
43. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
44. Determinants of circulating insulin-like growth factor-I
45. Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins
46. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3
47. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: Genetic versus environmental regulation